ecancermedicalscience

Submit article

https://doi.org/10.3332/ecancer.2014.468

Abstract | Full Article |

Case Report

Leptomeningeal carcinomatosis associated with papillary renal cell carcinoma

2 Oct 2014

Abhishek Chilkulwar, Ramya Pottimutyapu, Fawng Wu, Keerthi R Padooru, Sai Ravi Pingali, Mohammed Kassem

Leptomeningeal carcinomatosis (LMC), or neoplastic meningitis, occurs in about 5–20% of patients with metastatic cancer, depending on the type of the primary malignancy and kind of treatment received. The association of LMC with renal cell carcinoma (RCC) is a rare entity, and only two cases of papillary renal cell cancer with leptomeningeal metastasis have been reported. Leptomeningeal spread usually confers a poor prognosis despite the use of modern treatment strategies as compared to patients with extracranial metastases. We report a case of papillary RCC, a less common type of RCC presenting with LMC.

Article metrics: 1971 views

663

1308

1937-dehyart-trial-study-protocol-for-phase-2-randomised-controlled-study-assessing-the-role-of-dose-escalation-using-18f-fluoromisonidazole-positron-emission-tomography-computed-tomography-in-head-and-neck-cancers

Clinical Study: DEHyART trial: Study protocol for phase 2 randomised controlled study assessing the role of dose escalation using [18F] fluoromisonidazole positron emission tomography/computed tomography in head and neck cancers

Sarthak Tandon, Manoj Gupta, Parveen Ahlawat, Madhur Verma, Apoorva Nayak, Akash Bellige, Kundan S Chufal, Jaskaran S Sethi, Anjali Pahuja, Shreya Rai, Abhishek Singh, Vikas Arora, Vishal Yadav, David K Simson, Irfan Ahmad, Sandeep Singh, Dipesh Vashisht, Azhar Ansari, Rashmi Bansal, Abhishek Bhadri, Harsh Vyas, Manindra Mishra, Rajat Saha, Mudit Agarwal, Partha S Chowdhary, Ajay K Dewan, Munish Gairola

2 Jul 2025

https://doi.org/10.3332/ecancer.2025.1937

Abstract | Full Article | PDF